biotech
New drug pricing plans will ‘damage UK biotech’
August 16, 2013Research and Development, Sales and Marketing BIA, Hunt, NHS, VBP, bates, biotech
The BioIndustry Association is warning that the government’s new drug pricing scheme could put future investment in the UK’s biotech …
Oxyrane brings on board senior team
January 30, 2013Manufacturing and Production, Research and Development, Sales and Marketing Oxyrane, biotech
UK biotech firm Oxyrane has expanded to the US and made a number of senior appointments. The privately-owned Manchester-based company’s first …
Parexel’s BioPharm Unit to aid smaller R&D firms
July 25, 2012Research and Development Parexel, R&D, biotech
Parexel has launched the Parexel BioPharm Unit – a new division focused on the needs of small and mid-sized biopharma …
Significant reorganisation for Chelsea Therapeutics
July 11, 2012Research and Development, Sales and Marketing Chelsea Therapeutics, Northera, biopharma, biotech
Biopharma development firm Chelsea Therapeutics has announced a major corporate reorganisation. The move includes a significant reduction in headcount, the …
British biotech industry gains £200m boost
March 21, 2012Research and Development, Sales and Marketing GSK, Wellcome Trust, biotech, fund
The Wellcome Trust is to launch a £200 million business that will invest in emerging healthcare and life sciences firms. …
Moving towards milestones: the evolving pharma – biotech relationship
January 24, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Deals, Susan Aldridge, biotech, pharma
Big pharma is going through the greatest ever wave of patent expiries, while small biotechs are finding it hard to …
GSK invests in UK biotech start-up
August 22, 2011Research and Development Autifony, GSK, biotech, hearing loss, research and development news
GlaxoSmithKline has taken a £1.3 million stake in a new UK biotech spin-out that will develop pharmacological treatments for hearing …
BMS makes $325m biotech acquisition
July 25, 2011Research and Development, Sales and Marketing BMS, biotech, research and development news
Bristol-Myers Squibb is to plug gaps in its pipeline by buying private biotech company Amira Pharmaceuticals for $325 million in …
Actelion plans biotech start-up
June 20, 2011Research and Development Actelion, biotech
Swiss biopharmaceutical company Actelion is planning to launch a biotech start-up that would run separately from the main company. It …
Promoting UK biotech’s voice and mission
June 8, 2011Research and Development ERBI, One Nucleus, biotech
One Nucleus is a new organisation formed from the merger of two of England’s regional networks – ERBI (Eastern Region …
British biotech: rebuilding momentum
May 26, 2011Research and Development UK, biotech, biotech funding
Since biotech first emerged in the UK in the late 1980s, the dream has always been for the country to …
Circassia raises funds to develop allergy products
April 19, 2011Research and Development Circassia, UK biotech, biotech
UK biopharma company Circassia has raised £60 million funding for the final stage of development of its anti-allergy products. The …
TcL Pharma appoints French pharma veterans
April 1, 2011Research and Development, Sales and Marketing TcL, appointment, biotech, recruitment
TcL Pharma has appointed two seasoned veterans of the French pharmaceutical industry. Dr Jean-Hugues Masgnaux joins the French biotech company …
Biotech lobbies for further UK tax breaks
March 17, 2011Research and Development BIA, R&D tax credits, biotech
Biotech companies are calling on Chancellor George Osborne to provide extra incentives for research in his forthcoming Budget. The budget …
Scottish biotech ProStrakan sold for £292m
February 22, 2011Research and Development KHK, Kyowa Hakko Kirin, ProStrakan, Scottish biotech, biotech
Scottish biotech ProStrakan is to be bought by Japanese manufacturer Kyowa Hakko Kirin for £292 million. The companies agreed the …
Latest content
